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ABSTRACT 
Epidemiological studies showed an association between menopause, weight gain and risk factors that identify the 
metabolic syndrome (MS). We evaluated body composition and metabolic risk factors in postmenopausal women ad-
dressed to a center for the assessment of nutritional status to lose weight by hypocaloric balanced diet. 161 postmeno-
pausal women were enrolled. MS diagnosis was made applying IDF (International Diabetes Foundation) criteria. After 
the prescription of hypocaloric diet all subjects were controlled every 2 months. In patients suffering from MS (MS+) at 
the first visit, diagnosis of MS was reassessed when 10% weight loss was achieved. 70 women were MS+. Years since 
menopause, low instruction level, obesity and Visceral Adipose Tissue (VAT) were each associated with MS. Particu- 
larly, BMI ≥ 30 Kg/m2 (OR: 2.61; 95% CI, 1.76 - 3.46) and VAT > 6.6 cm (OR: 3.49; 95% CI, 2.52 - 4.46) resulted 
independent risk factors. The 30% of the whole sample dropped out, the reminders significantly reduced weight, waist 
circumference (Wc) and Fat Mass (p < 0.01). The 35% of MS+ women achieved the 10% weight loss with significant 
reduction of VAT, Wc, fasting glucose, tryglicerides, blood pressure and resolution of MS in the 78% of them. The 
43.5% of postmenopausal women addressed in one center for the assessment of nutritional status to follow a 
weight-loss nutritional program had the MS; visceral obesity was the strongest independent risk factor and hypocaloric 
balanced diet resulted a good strategy to lose weight and treat MS. 
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1. Introduction 
Menopause is one of the critical periods of a woman’s 
life during which weight gain is favored [1] and obesity 
prevalence is the highest across lifespan [2-4].  
Epidemiological data suggest that weight gain during 
the menopausal transition is due to aging, decreased lei-
sure-time physical activity, and hormonal changes [1,5]. 
Aging and reduced physical activity were associated to a 
gradual decrease of FFM (Fat-Free Mass) with conse-
quent reduction on RMR (Resting Metabolic Rate) and 
increased body fat [6]. Furthermore the decline of en-
dogenous estrogens induces the increase of visceral adi-
posity [7].  
There is increasing evidence that weight gain and in 
particular visceral obesity are predictors of metabolic 
alterations including insulin resistance, glucose intoler-
ance, lipid disorders and high blood pressure [8]. This  
cluster of risk factors identifies the metabolic syndrome 
(MS).  
Data in literature showed that both nutritional status 
and postmenopausal status play an important role as de-
terminant of MS. Case CC et al. [9] showed that MS was 
prevalent in 68% of a cohort of 185 obese individuals. 
Dietary patterns are associated with glucose intolerance, 
insulin resistance and other features of the metabolic 
syndrome. In particular scientific evidences recommen- 
ded a healthy balanced diet, with Mediterranean diet cha- 
racteristics (fruit and vegetables, legumes, whole grains, 
dietary fiber, fish, vegetable protein and vegetable fat 
from olive oil) as the main components of metabolic 
syndrome and chronic diseases prevention [10,11]. 
Studies performed on postmenopausal women showed 
that 13.7% to 41.5% had the MS [12-14]; moreover 
postmenopausal status according to years since meno-  *Corresponding author. 
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pause was identified as an independent risk factor for MS 
[15]. Finally epidemiological studies showed that preva- 
lence of MS tended to increase steadily in parallel with a 
marked rise in BMI and waist circumference through the 
menopausal transition [16].  
MS is associated to an increased cardiovascular risk. 
Epidemiological studies have shown that individuals 
with the MS have a three fold increase in cardiovascular 
diseases and a significant increase in cardiovascular 
mortality [17].  
The management of MS is thus a necessary strategy to 
improve cardiovascular risk. At this purpose current 
guidelines (International Diabetes Foundation, 2005) 
propose weight loss as one of the first therapeutic goal to 
achieve [18]. For instance, Case CC et al. (2002) [9] 
showed that moderate weight loss with a very low calorie 
diet markedly improved all aspects of MS in obese indi-
viduals.  
Although the relationship between nutritional status 
and MS [8,9] and between menopause and MS has been 
documented [7,19], no study focused on MS in post- 
menopausal women who seek a weight-loss program, nor 
the effects of a structured dietary intervention in this kind 
of individuals has been reported.  
Therefore in this study we observed the prevalence of 
MS among postmenopausal in one center for the assess-
ment of nutritional status and we examined the efficacy 
of a hypocaloric balanced diet on the improvement of 
nutritional status and on management of MS. 
2. Methods 
2.1. Study Subjects 
The study was performed at the International Center for 
the Assessment of Nutritional Status (ICANS), Univer-
sity of Milan (Italy). Study subjects were recruited 
among Caucasian postmenopausal women who sponta-
neously came to ICANS for weight loses. Menopausal 
status was identified as the absence of menses for at least 
12 consecutive months or as current hormonal replace-
ment therapy after menopause diagnosis by a gynaecolo- 
gist or as surgical menopause. Exclusion criteria com- 
prised psychiatric disorders, cancer, severe cardiovascu- 
lar events and chronic illness affecting nutritional status. 
The present study was carried out according to the guide- 
lines of the Declaration of Helsinki and written informed 
consent was obtained from every patient before meas- 
urements were made. The institutional review board ap-
proved the study procedures. 
2.2. Experimental Design 
At the beginning of the study every woman underwent a 
clinical and nutritional status evaluation composed by 
medical examination, body composition assessment (an- 
thropometry and ultrasonography of visceral abdominal 
fat), lifestyle and dietary habits investigation, indirect 
calorimetry for resting energy expenditure measurement, 
blood pressure measurement, examination of biomedical 
parameters related to MS.  
Patients underwent check up every two months in or- 
der to evaluate the compliance to dietary intervention (by 
an interview with the dietician), and the effects on nutria- 
tional status (by anthropometry and blood pressure 
measurement). 
In patients resulted affected by MS at the first visit, the 
diagnosis of MS was reassessed when 10% weight loss 
was achieved and visceral abdominal fat (VAT) and 
biochemical parameters were reassessed.  
2.3. Anthropometry 
Anthropometric measurements were taken by the same 
operator, according to standard criteria and measuring 
procedures [20]. 
With a subject wearing only underwear, weight (to the 
nearest 0.1 kg) and standing height (SH; to the nearest 
0.1 cm) were measured using the same calibrated scale 
that had a telescopic vertical steel stadiometer (SECA 
711, Hamburg, Germany).  
BMI (Body Mass Index) was calculated as weight 
(kg)/stature (m)2. Waist circumference (Wc) was meas- 
ured as proposed by Lohman et al. [20].  
To measure Wc, the top of iliac crest and the end of 
the last rib were located. A measuring tape was placed in 
a horizontal plane around abdomen at level of the mean 
point between iliac crest and last rib. Before reading tape 
measure, we ensured that tape is snug but did not com- 
press the skin and was parallel to floor. Measurement 
was made at the end of a normal expiration. 
Skinfold thickness was measured as proposed by 
Lohman et al. [20] using a Holtain LTD calliper. Biceps, 
triceps, subscapular and soprailiac skinfolds were con- 
sidered in analysis of body density and fat mass (FM) 
(%), which were calculated by the Durnin and Womer-
sley method and by Siri’s formula, respectively [21].  
Visceral adipose tissue (VAT) was measured by a 
physician using ultrasonography (US). All ultrasono-
graphic procedures were performed by the same exam-
iner using a 3.5-MHz probe located 1 cm from the um-
bilicus. Two US measurements of intraabdominal (“vis-
ceral”) and subcutaneous fat were taken. US-determined 
subcutaneous fat was defined as the distance between the 
skin and external face of the rectus abdominal muscle, 
and visceral fat was defined as the distance between the 
internal face of the same muscle and the anterior wall of  
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the aorta [22]. 
2.4. Indirect Calorimetry  
Resting Energy Expenditure (REE) was estimated by an 
open-circuit ventilated-hood system (Sensor Medics 
Wmax29, Anaheim, CA). All measurements were made in 
the post-absorptive state (12 - 14 h fasting) in a thermo 
neutral environment (24˚C - 26˚C) and with no external 
stimulations. The subjects were allowed to rest awake in 
the supine position for at least 20 min prior to the meas-
urement. About 30 min of respiratory gas exchange data 
were then collected. The first 5 - 10 min of data were 
discarded, as recommended by Isbell et al. [23] This al- 
lowed the subjects to acclimate to the canopy and to the 
instrument noise. The average of the last 20 min of 
measurements was used to determine REE for 24 h ac- 
cording to standard abbreviated Weir equation [24]. The 
measured REE was compared with the predicted REE, 
according to the equations of Harris and Benedict [25]. 
2.5. Blood Pressure Measurement 
Blood pressure (BP) was measured with a random-zero 
mercury sphygmomanometer by a physician after at least 
a 10-min rest.  
2.6. Definition of Metabolic Syndrome  
The Metabolic Syndrome was defined using criteria pro- 
posed by the International Diabetes Foundation (IDF) 
(2005). The IDF clinical definition makes the presence of 
abdominal obesity necessary for diagnosis: for women of 
European origin, such as the subjects of this study, the 
IDF specified thresholds for abdominal obesity to be 
waist circumference ≥80 cm. When such is present, two 
additional factors of the following listed are sufficient for 
diagnosis: triglycerides ≥150 mg/dl or drug therapy for 
elevated triglycerides, HDL cholesterol <50 mg/dl or 
drug therapy for reduced HDL, systolic pressure ≥130 
mmHg or diastolic pressure ≥85 mmHg or antihyperten-
sive drug treatment, fasting glucose ≥100 mg/dl or drug 
treatment for elevated glucose. On the basis of the pres-
ence or not of MS, the sample was divided in two groups: 
MS+ and MS−. 
2.7. Dietary Intervention 
After the first visit all women received a dietary program 
providing at least the 90% of resting energy expenditure 
and structured on the indications from Guides Lines for 
an Healthy Nutrition [26] and Recommended Assump-
tion Levels of Energy and Nutrients for Italian Popula-
tion [27]. The macronutrient composition of the dietary 
programs were balanced in macronutrient composition as  
indicated in Table 1. Three-five servings of fruit and 
vegetables were daily advised; the source of protein in-
take was dependent on the frequencies of consumption of 
meat (2 times/weeks), fish (4 times/week), legumes (4 
times/week), eggs (1 time/week), low-fat cheese (1 - 2 
time/week), low-fat ham (1 - 2 time/week). Olive oil is 
indicated as the main culinary lipid. Dietary cholesterol 
was lower than 200 mg/die and fibre intake was about 30 
g, in agreement with Guide Lines for a Healthy Nutri- 
tion.  
2.8. Statistical Analysis 
Statistical analysis was performed using Statistix V. 7.0. 
All data were expressed as mean ± sd for continuous 
variables and as % for categorical variables. Variable 
continuous and categorical in MS+ and MS− women were 
compared using Student’s t test and the X2 test respec-
tively. Quartiles of VAT were indicated as median and 
range. 
Univariate and multivariate logistic regression analysis 
were used to calculate the crude and adjusted odds ratios 
(ORs) considering age, years since menopause, surgical 
menopause, instruction level, obesity and VAT as poten-
tial risk factors associated with MS in menopause. ORs 
were expressed with 95% confidence intervals (CI). 
All comparisons were made two-sided, and a p value < 
0.05 (two-tailed) was considered significant. 
3. Results 
Between November 2010 and March 2011, 677 subjects 
spontaneously referred to ICANS to obtain dietary treat- 
ment. Among them, 161 were postmenopausal women, 
of which 10% normal weight (18.5 ≤ BMI ≤ 24.9 Kg/m2), 
45% overweight (25 ≤ BMI ≤ 29.9 Kg/m2) and 45% 
obese (BMI ≥ 30 Kg/m2). One hundred fifty-five post-
menopausal women showed a Wc ≥ 80 cm and among 
these, 70 showed at least two additional factors to make 
diagnosis of MS. Therefore the 43.5% of postmenopausal 
sample was suffering from MS. 
 
Table 1. Energy and Macronutrient composition of dietary 
protocols. 
 MS+ (n = 70) MS− (n = 91) p 
EI (kcal/d) 1309 ± 114 1346 ± 132 0.1 
Protein (g/BW) 0.9 ± 0.1 0.8 ± 0.1 0.7 
Fat (%EI) 24 ± 1.4 24 ± 1.6 0.8 
Saturated fat (%EI) 6.5 ± 0.4 7.0 ± 0.5 0.7 
Carbohydrates (%EI) 56.2 ± 1.3 56.0 ± 1.2 0.8 
Simple carbohydrates (%EI) 9.0 ± 1.2 9.0 ± 0.9 0.9 
EI: Energy Intake; BW: Body Weight. 
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The distribution of MS in relation to BMI resulted: 
67% among obese woman, 26% among overweight and 
29% among normal weight.  
3.1. Characteristics of the Study Sample at  
Baseline 
The characteristics of the study sample at baseline, di-
vided in MS+ and MS− groups, are presented in Table 2. 
The MS+ sample resulted slightly older and with a 
greater duration of menopause than MS− sample. More-
over we observed in MS+ women a greater prevalence of 
surgical menopause and of low instruction level. Com-
pared with MS− women, MS+ women had a greater 
weight, BMI, Wc, FM, VAT, BP, fasting glucose and a 
lower HDL cholesterol. REE, but not REE/BW, resulted 
greater in MS+ women (1392 ± 167 kcal vs 1452 ± 180 
kcal, p = 0.01; 18.4 ± 1.9 kcal/kg vs 18 ± 1.8 kcal/kg, p = 
0.1). No significance difference was observed between 
measured REE and predicted REE in both groups (MS+: 
+2% ± 8%, p = 0.1; MS−: −1% ± 7.5%, p = 0.1).  
With respect MS−, MS+ women were more frequently 
obese (67% vs 27%, p = 0.01), less frequently over-
weight (24% vs 59%, p = 0.04) and similarly normal 
weight (9% vs 13%, p = 0.3). 
VAT thickness was categorized in quartiles and related 
to relative MS frequency as shown in Table 3. Only the 
subjects in the highest quartile had significantly higher 
MS prevalence than subjects in the lowest quartiles.  
Results of multiple logistic regression are summarized 
in Table 4. 
Univariate analysis showed age, postmenopausal sta- 
tus since at least 5 years, low instruction level, obesity 
(BMI ≥ 30 Kg/m2) and VAT > 6.6 cm as predictors of 
MS in menopause; multivariate analysis showed the BMI 
≥ 30 Kg/m2 and VAT > 6.6 cm as independent risk fac- 
tors. 
Table 5 describes the prevalence of individual com-
ponents of MS at baseline. Among criteria for MS diag-
nosis, hypertension was the most frequently met fol-
lowed by hypertriglyceridemia, altered fasting glucose 
and low HDL cholesterol. Although Wc ≥ 80 cm is the 
main and essential criterion for MS, however the differ-
ence between MS+ women and MS− women was margin-
ally significant (p = 0.05).  
3.2. Dietary Intervention: Compliance and  
Effects on the Study Sample 
The 30% (n = 48) of the whole sample dropped out just 
after two months of diet therapy. No significant differ-
ence was observed in the frequency of drop-out between 
MS+ and MS− groups (33%, n = 18 vs 26%, n = 30, p = 
0.3). 
The subjects that complied with dietary program (n = 
113) followed it on average for 4 months without sig- 
nificant differences between MS+ (n = 52) and MS− (n = 
61) women (3.8 ± 1.7 vs 4.0 ± 2.1 months, p = 0.5).  
As shown in Table 6 a significant reduction of weight, 
Wc and FM was observed after the dietary intervention 
(p < 0.001) in the whole sample. In particular MS+ 
women achieved a significantly greater reduction in BMI 
and Wc than MS− women (p < 0.05). 
An improvement of BP such as diastolic values (−1.6 
± 7.9 mmHg, p = 0.01) than sistolic values (−3.2 ± 4.7 
mmHg, p = 0.03) was reported in MS+ women. In par-
ticular we observed a normalization of blood pressure on 
the basis of IDF criteria in 34.3% (n = 12) of MS+ 
women completers that at begin of the study had alter-
ated blood pressure (n = 35).  
No significant BP change was reported in MS− wo- 
men.  
3.3. Effects of 10% Weight Loss in MS+ Women 
The therapeutic goal of 10% weight loss in presence of 
MS was achieved by 18 women (35% of the compliant 
MS+ sample). 
The mean time of dietary intervention to achieve this 
therapeutic goal was 5.1 ± 1.5 months (range 3 - 9 
months). 
In Table 7 are summarized results about effects of 
10% weight loss on body composition and individual 
components of MS. Significant reductions were observed 
in BMI, FM% and VAT (p < 0.01). The prevalence of 
obesity in MS+ sample reduced significantly (−54%, p = 
0.01). Significant changes are obtained as mean value of 
Wc, basal glucose and blood pressure (p < 0.01). 
On the basis of IDF criteria for MS diagnosis we ob-
served significant reduction in the frequency of altered 
basal glucose, hypertrigliceridemia and hypertension. No 
significant difference was observed in the frequency of 
Wc ≥ 80 cm. The 10% weight loss was associated to the 
resolution of MS in the 78% of the MS+ cases (p = 
0.001). 
4. Discussion 
We reported data extracted from an observational study 
carried out on postmenopausal women that spontane-
ously underwent a structured weight loss program in one 
center for the assessment of nutritional status. We fo-
cused our attention on body composition and metabolic 
risk factors and on effects of a hypocaloric balanced diet 
on the improvement of nutritional status and on man-
agement of MS. 
The 43.5% of our sample had the MS; since we in-
cluded women who wanted to lose weight because un-  
Body Composition and Metabolic Risk Factors in Postmenopausal Women:  
Effects of a Dietary Weight Loss Program 
Copyright © 2013 SciRes.                                                                                  FNS 
424 
  
Table 2. Characteristics of the study sample at baseline. 
  Total sample MS+ MS− p 
N  161 70 91  
Age y 60.1 ± 7.4 61.6 ± 7.4 58.9 ± 7.3 0.02 
Characteristics of menopause      
Menopausal age y 50.0 ± 3.4 49.8 ± 3.9 50.2 ± 3 0.4 
Years since menopause y 10.1 ± 7.8 11.6 ± 7.8 9 ± 7.6 0.03 
Surgical menopause % 14 20 9 0.04 
HRT in the present % 6 11 8 0.4 
HRT in the past % 3 3 3 0.8 
Educational Level      
Primary school  9 16 4 0.03 
Compulsory education  16 19 13  
Secondary school  43 37 47  
Degree certificate  25 20 30  
Other  7 8 6  
Occupation %     
Housewife  29 24 32 0.17 
Retired  37 47 31  
Employed  34 29 37  
Civil status %     
Unmarried  13 14 12 0.78 
Married  69 66 72  
Divorced  9 10 9  
Widow  9 10 7  
Exercise in leasure time %     
Active ≥ 1h/w  45 39 48 0.2 
Inactive  55 61 52  
Smoking %     
Current  25 29 22 0.46 
Former  33 37 46  
Never  42 34 32  
Pregnancies %     
None  12 7 16 0.07 
≥1  88 93 84  
Body composition      
Weight kg 76.3 ± 12 81.4 ± 12.9 72.6 ± 9.6 0.001 
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Continued 
BMI Kg/m2 30.3 ± 4.7 32.7 ± 5.2 28.4 ± 3.5 0.001 
Wc cm 97.7 ± 12 103.4 ± 11.6 93.3 ± 9.3 0.001 
FM % 42.4 ± 3.3 43.5 ± 3 41.6 ± 3.3 0.001 
VAT cm 5.2 ± 2.6 6.3 ± 3 4.6 ± 1.9 0.001 
Biochemical parameters mg/dl     
Fasting glucose  96.5 ± 14 103.6 ± 16 91.1 ± 10.3 0.001 
Total cholesterol  231.6 ± 37 227.5 ± 41 234.5 ± 33.9 0.2 
HDL cholesterol  61.4 ± 14 55.1 ± 11.8 66.1 ± 14 0.001 
LDL cholesterol  145 ± 34 146.0 ± 39 144.0 ± 30.1 0.7 
Triglycerides  116 ± 53 140.6 ± 62.5 98.9 ± 34.2 0.2 
Blood pressure (BP) mmHg     
Diastolic BP  78.3 ± 8.4 81.5 ± 7.9 75.9 ± 7.9 0.001 
Sistolic BP  126.8 ± 13 132 ± 11.7 122.3 ± 12.5 0.001 
HRT: hormonal replacement therapy; BMI: body mass index; WC: waist circumference; FM: fat mass; VAT: visceral Adipose tissue; BP: blood pressure; BW: 
body weight; Metabolic risk factors are underlined; Data are mean ± SD or %; p value calculated by student’s t test (continuous data) or X2 test (categorical 
data). 
 
Table 3. Quartiles of VAT thickness and relative frequency of MS. 
  Quartiles of VAT   
 Q1 (n = 40) Q2 (n = 40) Q3 (n = 40) Q4 (n = 41) 
VAT (cm)     
median 2.6 4.2 5.8 8.3 
range 1.3 - 3.2 3.3 - 4.8 4.9 - 6.6 6.7 - 16.4 
MS+ (%) 35 28 30 78 
X2 Test vs Q1 (p-value)  0.47 0.44 0.001 
 
Table 4. Univariate and multivariate ORs for the metabolic syndrome. 
 Crude ORs (95%CI) p Adjusted ORs (95%CI) p 
Age, y 1.05 (1.01 - 1.09) 0.02 1.03 (0.96 - 1.01) 0.38 
Years since menopausea, y 1.05 (1.00 - 1.09) 0.04 1.016 (0.13 - 2.19) 0.77 
Surgical menopause 1.33 (0.21 - 2.45) 0.6 1.95 (0.68 - 3.2) 0.29 
Education levelb 2.70 (1.94 - 3.46) 0.009 1.92 (1.03 - 2.8) 0.14 
BMIc, kg/m2 5.02 (4.34 - 5.71) 0.001 2.61 (1.76 - 3.46) 0.02 
VATd, cm 8.6 (7.76 - 9.45) 0.001 3.49 (2.52 - 4.46) 0.01 
OR: odds ratio; BMI: body mass index; VAT: visceral adipose tissue; aat least 5 years since menopause; beducation level < secondary school; cBMI ≥ 30 kg/m2; 
dVAT > 6.6 cm; ORs were adjusted for all other covariates in the model. 
 
easy or worried about their inadequate nutritional status, 
this date suggests a good agreement between the percep-
tion of an alteration of nutritional status and the effective 
presence of metabolic risk factors. Thus, to awaken the 
postmenopausal population to weight control could be a 
good strategy in order to individuate health risk condi-
tions such as the MS. 
Epidemiological studies showed that MS is largely 
determined by overweight status and obesity [28]. 
Case et al. (2002) [9] reported that MS is prevalent in   
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Table 5. Prevalence (%) of individual components of the metabolic syndrome. 
Components of the metabolic syndrome MS+ (n = 70) MS− (n = 91) p 
Wc ≥ 80 cm 100 86 0.05 
HDL cholesterol < 50 mg/dl 38 21 0.001 
Triglycerides ≥ 150 mg/dl 44 23 0.001 
Hypertension ≥ 130 mmHg systolic or ≥ 85 mmHg diastolic 70 46 0.003 
Fasting glucose ≥ 100 mg/dl 40 12 0.001 
p-value calculated by X2 test. 
 
Table 6. Effects of dietary intervention on body composition.  
 Total completer sample MS+ MS− p 
 n = 113 n = 52 n = 61 (MS+ vs MS−) 
Weight     
 (kg) −4.3 ± 3.8* −5.3 ± 4.6* −3.4 ± 2.7* 0.006 
 (%) −5.6 ± 4.8 −8.0 ± 5.6 −4.6 ± 4.2 0.01 
(kg)/diet months −1.2 ± 0.9 −1.3 ± 1.0 1.1 ± 0.8 0.16 
BMI     
 (kg/m2) −1.7 ± 1.5* −2.2 ± 1.8* −1.4 ± 1.2* 0.003 
(%) −5.6 ± 4.8 −8.0 ± 5.6 −4.6 ± 9.1 0.01 
Wc     
 (cm) −3.9 ± 3.5* −4.9 ± 3.9* −3.0 ± 2.9* 0.003 
 (%) −3.9 ± 3.4 −4.8 ± 3.7 −3.2 ± 3.0 0.016 
 (kg)/diet months −1.1 ± 0.9 −1.3 ± 0.8 0.9 ± 0.9 0.04 
FM%     
 −2.5 ± 2.1* −2.7 ± 2.4 −2.3 ± 1.7 0.2 
 (%) −6.0 ± 4.8 −6.3 ± 5.5 −5.7 ± 4.1 0.5 
/diet months 0.7 ± 0.6 0.7 ± 0.6 0.7 ± 0.6 0.9 
The results are expressed as mean and standard deviation (sd). BMI: body mass index; Wc: waist circumference; FM: fat mass. Δ delta: changes between T0 
(before dietary intervention) and T1 (after dietary intervention). Data T1 referred to the last control visit performed within the end of the study. *p < 0.01 be-
tween T0 and T1. 
 
two-thirds of obese individuals enrolling in a structured 
weight loss. In our study, the obesity condition was pre-
sent in the 45% of total sample; among obese women the 
67% met the IDF definition of MS. Although the two 
studies are different for criteria used (IDF vs ATP III), 
age and sex of the subjects, however both identified a 
similar prevalence of MS associated to obesity, confirm-
ing obesity as the predictor and the central feature of MS. 
Univariate and multivariate ORs for metabolic syndrome 
identified obesity as independent risk factor and one of 
the strongest predictor for the MS in menopause. 
Wc is an anthropometric index of abdominal VAT and 
an important predictor of the lipid and non-lipid abnor-
malities associated with MS [29]. In our sample we 
measured the thickness of VAT by ultrasonography and 
we confirmed a direct and significant correlation with 
Wc (r2 = 0.5, p = 0.001). However Wc ≥ 80 cm recom-
mended by IDF criteria as necessary risk factor to make 
diagnosis of MS was not a discriminating factor in our 
sample between MS+ and MS−: this was probably due to 
the high prevalence of overweight and obesity. Contrar-
ily, the measurement of VAT resulted a valid method to 
identify patients with MS; in particular we identified that, 
independently by BMI, the subjects with VAT > 6.6 cm 
have an increased risk of 4 fold for MS; this confirms the 
important role of visceral fat in the aetiology of MS.  
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Table 7. Individual components of MS and prevalence of 
MS in subjects MS+ at T0 that achieved the therapeutic goal 
of 10% weight loss (n = 18). 
N = 18 T0 T(−10% weight) % p 
Wc (cm)     
mean 102.7 94.1 −8.5 0.001
sd 10.7 10.3 3.1  
min 85.5 79.0 −3.9  
max 121.8 110.5 −15.2  
Fasting glucose (mg/dl)     
mean 104 93 −12.6 0.001
sd 9.1 7.5 5.6  
min 82 84.0 −2.9  
max 125 112.0 −23.6  
HDL cholesterol (mg/dl)     
mean 57 54 −7.6 0.06
sd 8 8.8 13  
min 46 41 13  
max 71 78 −29.4  
Triglycerides (mg/dl)     
mean 127 98 −12.4 0.15
sd 69 35 27  
min 61 54 30  
max 331 203 −71.3  
Diastolic pressure (mmHg)     
mean 84 76 −8 0.02
sd 5.5 3.9 7.3  
min 80 70 0  
max 95 80 −16.7  
Sistolic pressure (mmHg)     
mean 135 124 −7.2 0.05
sd 11.2 4.4 8.5  
min 120 120 4.2  
max 160 130 −21.9  
 
Moreover it was interesting to observe as pregnancy 
could predispose to VAT deposition: in our sample 
women who had at least one pregnancy showed, with 
respect women who did not have, a significant greater 
VAT (5.5 ± 2.4 cm vs 3.9 ± 1.9 cm, p = 0.03) and a 
greater prevalence of MS (46% vs 25%, p = 0.002).  
Concerning other risk factors investigated, education 
level resulted determinant of MS in univariate analysis; 
however multivariate analysis, adjusted for BMI, VAT 
and other confounding variables, showed that it is not an 
independent risk factor for MS. To explain this result we 
must consider that in our sample the 70% of subjects 
with a low level school was obese and among these the 
87% met IDF criteria for MS. Then, our results showed 
that prevalence of MS in women with low level school is 
probably a consequence of obesity condition. This is in 
agreement with epidemiological data that show that low 
education level, hampering the knowledge of health risk 
associated to wrong dietary habits, is associated at higher 
risk of obesity, independently by the age and sex [30]. 
As other investigators reported [31], in this study, 
postmenopausal status, according to years since meno-
pause, resulted a determinant for MS suggesting that the 
prevention of the risk factor for MS should begin in 
premenopausal age. 
In addition the surgical menopause was more frequent 
in MS+ sample with respect MS− sample, however it did 
not result a direct predictor for MS, in according with 
previous studies [32]. The difference observed thus is 
probably related to the effect of years since menopause: 
in fact surgical menopause usually occurs before than 
physiological menopause.  
Beyond to focus on body composition and metabolic 
risk factors in postmenopausal women, we examined the 
efficacy of a hypocaloric balanced diet on the improve-
ment of nutritional status and on management of MS. 
Drop-out rate found in our study was in according with 
drop-out rates reported in literature in obesity and over-
weight trials [33-35]. In compliant subjects the hypo-
caloric balanced diet resulted an effective method to lose 
weight and to modulate components of the metabolic 
syndrome. 
Although we observed a significant reduction in BMI, 
Wc and FM both in women MS+ than MS−, however it is 
interesting to observe that MS+ women achieved a better 
reduction in BMI and Wc than MS− in the same period 
time. Moreover the therapeutic goal of the 10% weight 
loss was achieved by 35% of MS+ subjects with respect 
the 23% of MS− (p = 0.03). This suggest that the com-
munication from a phisician of a diagnosis of MS and of 
related health risks could have induced a stronger moti-
vation in MS+ women to comply with dietary program. 
We were surprised to observe that despite this result, 
both MS+ and MS− showed a similar FM reduction. This 
depends on values of single skinfolds measured by pli-
cometry: in fact, we observed a greater reduction in MS+ 
with respect MS− women only for the biceps skinfold (p 
= 0.004), but not for triceps, subscapular and soprailiac  
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skinfolds. In particular it was interesting to observe a 
significantly greater reduction of Wc (p = 0.003), despite 
a similar reduction of sovrailiac skinfold (p = 0.2). Since 
skinfolds measured subcutaneous fat stores [20], while 
Wc was related to VAT, our results suggest that the bet-
ter weight loss obtained by MS+ group was associated 
more to a reduction of visceral than of subcutaneous fat. 
We showed that the 10% weight loss induced by the 
hypocaloric balanced diet in MS+ postmenopausal 
women resulted in substantial reduction of systolic and 
diastolic pressure, fasting glucose and triglycerides, in-
ducing a resolution of MS in the 78% of the sample. This 
result is in according with Case et al. [9] that studied the 
impact of weight loss by a moderate very low calorie diet 
on the metabolic syndrome in obese individuals. More-
over it is interesting to note that in our study the 10% 
weight loss was associated with a significant reduction of 
visceral obesity, even if there was not a significant re-
duction of the prevalence of Wc ≥ 80 cm; this result con-
firms the important role of visceral obesity as determi-
nant of MS and underscores the usefulness of ultrasono-
graphy method to measure and follow up VAT reduction 
overcoming the potential limitation of Wc as determinant 
of MS. 
In agreement with other studies [36], the main limita-
tion of dietary intervention performed in free living peo-
ple was the compliance at mid and long term. Although 
we confirmed that the 10% weight loss is an important 
therapeutical goal to achieve, because it is associated to 
the improvement and the resolution of MS, it is bewil-
dering to note that only the 35% of the MS+ women ob-
tained it. This result suggests the usefulness of strategies 
to increase the motivation and compliance of the patients, 
such as check-up at least every month with a dietician 
and psycological support when necessary, especially 
considering that menopause is a phase of the life associ-
ated to psychological distress and emotional symptoms 
[37], that could affect eating behaviour and compliance 
to nutritional programs.  
In conclusion this study showed a consistent occur-
rence of MS in postmenopausal women that decide vol-
untary to follow a weight-loss program, an important role 
played by VAT as predictor of MS and a good efficacy 
of the hypocaloric balanced diet to lose weight and to 
improve the main aspects of MS, with a significant re-
duction of its prevalence. 
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